Interact to see
Advertisement
Advertisement
HGHRX vs VGHCX
HGHRX vs VGHCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
HGHRX vs. VGHCX commentary
Aug 02, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HGHRX is a Buy and VGHCX is a Hold.
FUNDAMENTALS
Fundamentals
VGHCX has more cash in the bank: 36B vs. HGHRX (737M). VGHCX pays higher dividends than HGHRX: VGHCX (0.91) vs HGHRX (0.00). HGHRX was incepted earlier than VGHCX: HGHRX (19 years) vs VGHCX (41 years). HGHRX (1.63) is less costly to investors than VGHCX (0.37). HGHRX is a more actively managed with annual turnover of: 40.00 vs. VGHCX (29.00). HGHRX has a lower initial minimum investment than VGHCX: HGHRX (0) vs VGHCX (3000). HGHRX annual gain was more profitable for investors over the last year : -21.50 vs. VGHCX (-25.07). VGHCX (-21.39) and HGHRX (-22.46) have equivalent 5 years return.
| HGHRX | VGHCX | HGHRX / VGHCX | |
| Total Expense Ratio | 1.63 | 0.37 | 441% |
| Annual Report Gross Expense Ratio | 1.63 | 0.37 | 441% |
| Fund Existence | 19 years | 41 years | - |
| Gain YTD | -8.437 | -7.233 | 117% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 737M | 36B | 2% |
| Annual Yield % from dividends | 0.00 | 0.91 | - |
| Returns for 1 year | -21.50 | -25.07 | 86% |
| Returns for 3 years | -9.43 | -16.80 | 56% |
| Returns for 5 years | -22.46 | -21.39 | 105% |
| Returns for 10 years | -25.96 | -29.28 | 89% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement